Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia

This publication has 18 references indexed in Scilit:

• A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias
  New England Journal of Medicine, 1993
• Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
  The American Journal of Cardiology, 1993
• To prolong refractoriness or to delay conduction (or both)?
  European Heart Journal, 1992
• Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris
  The American Journal of Cardiology, 1992
• Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay
  Journal of Pharmaceutical and Biomedical Analysis, 1991
• A dose‐ranging study of UK‐68,798, a novel class III anti‐arrhythmic agent, in normal volunteers.
  British Journal of Clinical Pharmacology, 1991
• Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
  Circulation, 1990
• Cardiodepressive effects of antiarrhythmic drugs
  European Heart Journal, 1989
• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989
• Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: Evaluation in a conscious canine model of sudden death
  Journal of the American College of Cardiology, 1987